Gabelli Funds’s GenMark Diagnostics, Inc GNMK Stock Holding History

Gabelli Funds’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-377,505	Closed	-$9.02M	–	1470
2021 Q1	$9.02M	Buy	+377,505	New	+$7.02M	0.06%	368
2020 Q2	–	Sell	-10,370	Closed	-$43K	–	1089
2020 Q1	$43K	Hold	10,370	–	–	﹤0.01%	1038
2019 Q4	$50K	Hold	10,370	–	–	﹤0.01%	1072
2019 Q3	$63K	Hold	10,370	–	–	﹤0.01%	1091
2019 Q2	$67K	Hold	10,370	–	–	﹤0.01%	1126
2019 Q1	$74K	Hold	10,370	–	–	﹤0.01%	1112
2018 Q4	$50K	Hold	10,370	–	–	﹤0.01%	1124
2018 Q3	$76K	Hold	10,370	–	–	﹤0.01%	1134
2018 Q2	$66K	Hold	10,370	–	–	﹤0.01%	1136
2018 Q1	$56K	Buy	+10,370	New	+$51.5K	﹤0.01%	1137

Gabelli Funds's GNMK Position: Q2 2021 in Review

Gabelli Funds sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 377,505 shares — an estimated $9.02M sold.

Gabelli Funds first reported a position in GNMK in Q1 2018 and held it in 10 quarters. The position peaked at $9.02M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Gabelli Funds reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Gabelli Funds sold 377,505 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $9.02M.
Gabelli Funds first reported a position in GenMark Diagnostics, Inc in Q1 2018 and held it in 10 quarters.
Gabelli Funds's GenMark Diagnostics, Inc position peaked at $9.02M in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Gabelli Funds's 13F filing for Q2 2021, filed 13 Aug 2021.